SYNCRIP and hepatocellular carcinoma: Studies have shown that SYNCRIP expression can indicate a poor prognosis of HCC (Uhlen et al., 2017), and SYNCRIP can stimulate the progression of HCC by controlling the epithelial-mesenchymal transition of HCC (Riccioni et al., 2022).